Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

11.64 +0.09 (+0.78%)
Streaming Delayed Price Updated: 10:03 AM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cassava Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell. 
Via InvestorPlace
Top 5 Health Care Stocks That May Explode In July
Via Benzinga
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Cassava Sciences Stock Is Sinking Today
The biotech stock is feeling the heat from an indictment of a former consultant. 
Via The Motley Fool
Peering Into Cassava Sciences's Recent Short Interest
Via Benzinga
(SAVA) - Analyzing Cassava Sciences's Short Interest
Via Benzinga
Cassava Sciences: Q4 Earnings Insights
Via Benzinga
Is There Any Hope for Cassava Sciences Stock?
Battered by controversy, this company will need to show real results to prosper. 
Via The Motley Fool
Planet Labs Layoffs 2024: What to Know About the Latest Planet Job Cuts
Planet Labs layoffs are a hot topic on Monday as the satellite company prepares to cut 180 jobs, or 17% of its workforce, to reduce costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Cassava Sciences Cooperates With DOJ, SEC On Controversial Alzheimer's Drug Investigation
Cassava Sciences is cooperating with DOJ and SEC investigations involving its Alzheimer's drug simufilam. An internal committee is examining new SEC information, while the company advances its Phase 3... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Are Stocks Down Today?
Stocks are down today and investors wondering why have come to the right place as we know what's sending shares lower on Monday! 
Via InvestorPlace
SAVA Stock Alert: Former Cassava Science Advisor Charged With Fraud
SAVA stock is trading lower after a scientist behind Cassava's simufilam was charged with manipulating research data to justify his grants. 
Via InvestorPlace
Cassava Shares Are Down Over 30%: Here's Why
Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading significantly lower on Friday following the indictment of Hoau-Yan Wang, a tenured medical professor and advisor to the company, by a federal... 
Via Benzinga
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
(SAVA) - Analyzing Cassava Sciences's Short Interest
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024
SAVA stock results show that Cassava Sciences beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Biotech Stocks
As the stock market corrects, focusing on stable investments is crucial. This is why you should steer clear of these biotech stocks to avoid. 
Via InvestorPlace
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration. 
Via Benzinga
Exposures Product Safety
Boeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Monday, the U.S. stock market presented a mixed performance. The Dow Jones index managed to turn higher, trading up by 0.12% to 38,769.66. 
Via Benzinga
Topics Stocks
Exposures US Equities
Exit Now! 3 Biotech Stocks to Sell in February 2024
These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability. 
Via InvestorPlace
Why Is WiMi Hologram Cloud (WIMI) Stock Up 22% Today?
WiMi Hologram Cloud stock is taking off on Thursday with speculative trading as it rallies alongside another Chinese hologram company. 
Via InvestorPlace
MicroCloud Hologram (HOLO) Stock Pops Another 10% in Speculative Rally
MicroCloud Hologram stock is taking off on Thursday as speculative traders continue to bet on HOLO shares following a recent rally. 
Via InvestorPlace
Cassava Sciences (SAVA) Stock Pops on Positive Results in Simufilam Trial
SAVA stock jumped 9% on Wednesday after Casava Sciences shared promising results of a clinical trial of its Alzheimer's treatment. 
Via InvestorPlace
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
The top-line results showed no decline in cognition scores in patients with mild Alzheimer's disease who received simufilam continuously for 24 months. "We're fighting Alzheimer's disease by testing... 
Via Benzinga
3 Biotech Stocks to Sell in January Before They Crash and Burn
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell. 
Via InvestorPlace
Cassava Sciences Stock Continues Showing Rising Relative Strength
Cassava Sciences sees its Relative Strength Rating move into the elite 90-plus level. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.